LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Case Report/Series

Bedaquiline overdose: A case report

Telnov O, Alvarez V, Gragila E, Molfino L, du Cros PAK, Rich ML
Download
Download
Abstract
We present a case report describing outcomes in a 21 year old HIV-negative man who received treatment with bedaquiline. Due to error, dosage received comprised 4 pills of 100 mg every second day in the 60 days following the first two weeks of 4 pills of 100 mg every day. On detection, treatment was continued as per standard dosing of 200 mg given three times per week, with enhanced monitoring of ECG and liver function. The man was asymptomatic, with no signs of jaundice, abdominal pain, or abnormal heart rhythm. Toxic effects at this dosage were therefore not observed.
Countries
Mozambique
Subject Area
antibiotic resistancetuberculosisantimicrobial resistance
DOI
10.1016/j.ijid.2019.03.035
Published Date
02-Apr-2019
PubMed ID
30951878
Languages
English
Journal
International Journal of Infectious Diseases
Volume / Issue / Pages
Volume 84, Pages 138-140
Dimensions Badge